Posted On: 03/02/2014 11:24:33 PM
Post# of 70
BCLI Recent News
BrainStorm Cell Therapeutics awarded USD600,000 non-dilutive grant M2 - Wed Feb 26, 5:59AM CST
BrainStorm Receives Additional $600,000 Non-Dilutive Grant From Israel's Office of the Chief Scientist Marketwire - Tue Feb 25, 8:15AM CST
BrainStorm Issues Annual Letter to Shareholders Business Wire - Tue Feb 04, 7:00AM CST
BrainStorm Receives US Notice of Allowance for its Key Stem Cell Technology Patent Business Wire - Mon Feb 03, 7:00AM CST
BrainStorm Signs Definitive Agreement with Mayo Clinic for ALS Clinical Trial and NurOwn Manufacturing Business Wire - Wed Jan 29, 7:00AM CST
BrainStorm Hosting a Conference Call with Clinical Trial Advisors in Israel, US and Brazil to Update Shareholders on Current Developments Business Wire - Wed Jan 15, 7:00AM CST
BrainStorm Cell Therapeutics awarded US Patent Office's Notice of Allowance for stem cell technology M2 - Tue Jan 14, 4:51AM CST
BrainStorm Receives United States Patent Office Notice of Allowance for Its Stem Cell Technology Business Wire - Mon Jan 13, 8:42AM CST
BrainStorm Receives Notice of Allowance to Grant European Patent Covering its Stem Cells for the Treatment of CNS Diseases Business Wire - Wed Jan 08, 8:00AM CST
BrainStorm Cell Therapeutics awarded USD600,000 non-dilutive grant M2 - Wed Feb 26, 5:59AM CST
BrainStorm Receives Additional $600,000 Non-Dilutive Grant From Israel's Office of the Chief Scientist Marketwire - Tue Feb 25, 8:15AM CST
BrainStorm Issues Annual Letter to Shareholders Business Wire - Tue Feb 04, 7:00AM CST
BrainStorm Receives US Notice of Allowance for its Key Stem Cell Technology Patent Business Wire - Mon Feb 03, 7:00AM CST
BrainStorm Signs Definitive Agreement with Mayo Clinic for ALS Clinical Trial and NurOwn Manufacturing Business Wire - Wed Jan 29, 7:00AM CST
BrainStorm Hosting a Conference Call with Clinical Trial Advisors in Israel, US and Brazil to Update Shareholders on Current Developments Business Wire - Wed Jan 15, 7:00AM CST
BrainStorm Cell Therapeutics awarded US Patent Office's Notice of Allowance for stem cell technology M2 - Tue Jan 14, 4:51AM CST
BrainStorm Receives United States Patent Office Notice of Allowance for Its Stem Cell Technology Business Wire - Mon Jan 13, 8:42AM CST
BrainStorm Receives Notice of Allowance to Grant European Patent Covering its Stem Cells for the Treatment of CNS Diseases Business Wire - Wed Jan 08, 8:00AM CST
(0)
(0)
